Ayad Sarah, Gergis Kirolos, Mirza Noreen, Rayad Mohammad Nabil, Salamera Julius
Internal Medicine, Rutgers-New Jersey Medical School/Trinitas Regional Medical Center, Elizabeth, USA.
Internal Medicine, McLaren Flint Hospital, Flint, USA.
Cureus. 2021 Jun 1;13(6):e15377. doi: 10.7759/cureus.15377. eCollection 2021 Jun.
The use of highly active antiretroviral therapy (HAART) in the management and treatment of human immunodeficiency virus type 1 (HIV-1) has dramatically changed the course of the disease and improved overall survival. HAART results in significant decrease in viral load and enhancement of CD4 cells and gradual restoration of the immune system. However, a subset of patients may experience a paradoxical worsening after the initiation of HAART due to a heightened and dysregulated immune response. This phenomenon is termed immune reconstitution inflammatory syndrome (IRIS). The manifestation of Graves' disease (GD) after the introduction of HAART has been identified as IRIS manifestation in some patients. Thus, this occurrence should be suspected and further investigated in patients with HIV on antiretroviral therapy (ART) who present with symptoms consistent of hyperthyroidism to avoid overt hyperthyroidism. We report a case of IRIS associated Graves' disease. Our case adds to the very limited literature about this phenomenon.
在人类免疫缺陷病毒1型(HIV-1)的管理和治疗中使用高效抗逆转录病毒疗法(HAART)极大地改变了疾病进程并提高了总体生存率。HAART可显著降低病毒载量、增加CD4细胞数量并使免疫系统逐渐恢复。然而,一部分患者在开始HAART后可能会因免疫反应增强和失调而出现矛盾性恶化。这种现象被称为免疫重建炎症综合征(IRIS)。在一些患者中,HAART引入后格雷夫斯病(GD)的表现已被确定为IRIS表现。因此,对于接受抗逆转录病毒治疗(ART)且出现符合甲状腺功能亢进症状的HIV患者,应怀疑并进一步调查这种情况,以避免明显的甲状腺功能亢进。我们报告一例与IRIS相关的格雷夫斯病病例。我们的病例补充了关于这一现象的非常有限的文献。